Showing 1 - 10 of 14,266
not achieve their goal of democratizing access to vaccines. In this sense, the current TRIPS (Agreement on Trade … and access to COVID-19 vaccines (and other relevant technologies for control and treatment), the scenario after the … beginning of vaccination is marked by the deepening of vaccine nationalism, the concentration of inputs and vaccines production …
Persistent link: https://www.econbiz.de/10012496070
Persistent link: https://www.econbiz.de/10012433977
Persistent link: https://www.econbiz.de/10012433673
Persistent link: https://www.econbiz.de/10012434041
The purpose of this report is to analyze the impact that the COVID-19 pandemic has had on the vaccine industry from an … paradigm of competitive market efficiency with notorious market failures. We examine the impact of the pandemic on innovation … and the scientific, technological and industrial development of vaccines and find that certain elements of the industry …
Persistent link: https://www.econbiz.de/10014637110
), competition law and access to affordable life-saving treatments and vaccines. Compulsory licensing of patented medicines is a … extreme urgency" within the meaning of Article 31(b) of the TRIPS Agreement. Some legislations, such as European competition …
Persistent link: https://www.econbiz.de/10014541546
Rights (TRIPS Agreement) and Public Health adopted by the World Trade Organization, we realize that its impact is beyond … issues of public health stricto sensu. The Doha Declaration has inspired discussions at the Council for TRIPS regarding … of the discussion in the TRIPS Council is the need to rebalance public interests (such as public health and environmental …
Persistent link: https://www.econbiz.de/10014441903
Persistent link: https://www.econbiz.de/10012433661
applications. The antibody combination considered for the patent analysis in this paper are Casirivimab and Imdevimab. The vaccines …This paper provides an analysis of patents covering selected antibodies and vaccines used in the treatment or … prevention of COVID-19. The aim of the report is to support national patent offices and interested parties in developing …
Persistent link: https://www.econbiz.de/10014233696
This paper analyzes the debate over the international dissemination of data exclusivity as a form of protection for clinical trial data. This is a critical demand for pharmaceutical companies seeking larger market shares and longer periods of monopoly in order to recover investments in research...
Persistent link: https://www.econbiz.de/10014637112